Rare diseases
Investigational molecules
Locations
Back to Germany529 clinical trials in Freiburg Im Breisgau, Germany across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study of dupilumab effectiveness compared to placebo in adults with bullous pemphigoid
GermanyStudy of Ruxolitinib for Patients with High-Risk Polycythemia Vera or High-Risk Essential Thrombocythemia
GermanyStudy on Atezolizumab with Drug Combination for Patients with Gastric Cancer and Esophagogastric Junction Adenocarcinoma
GermanyStudy of Nivolumab for Patients with High-Risk Stage II Melanoma After Surgery
GermanyStudy of Pembrolizumab with Radiotherapy for Patients with Recurrent Prostate Cancer After Surgery
GermanyStudy of Sacituzumab Govitecan compared to standard therapy in HER2-negative breast cancer patients with high risk of relapse after neoadjuvant treatment
GermanyStudy on the Effectiveness and Safety of Fenebrutinib and Ocrelizumab for Adults with Primary Progressive Multiple Sclerosis
GermanyStudy on the Safety and Effectiveness of Azetukalner for Adults with Focal Epilepsy Taking 1 to 3 Anti-Seizure Medications
GermanyStudy on BI 1839100 for Reducing Cough in Patients with Idiopathic or Progressive Pulmonary Fibrosis
GermanyStudy on Durvalumab and Chemotherapy for Patients with Resectable Stage III Non-Small Cell Lung Cancer
GermanyStudy on the Effectiveness and Safety of Secukinumab for Patients with New-Onset Giant Cell Arteritis in Clinical Remission
GermanyStudy on Anifrolumab for Adults with Chronic or Subacute Cutaneous Lupus Erythematosus Unresponsive to Antimalarial Therapy
GermanyThe busiest research cities in the country
What the registry says about research in the country
Innovative trials focusing on breast cancer, non-small cell lung cancer, and colon cancer treatments. Studies evaluating new therapeutic approaches for both early-stage and advanced cancers.
Emphasis on targeted therapies and combination treatments to improve patient outcomes.
Research into treatments for psoriatic arthritis, rheumatoid arthritis, and Sjögren's disease. Studies evaluating novel biologics and targeted therapies.
Focus on improving disease control and quality of life for patients with chronic autoimmune conditions.
Clinical investigations of treatments for spinal muscular atrophy, sickle cell disease, and primary sclerosing cholangitis. Studies aimed at developing innovative therapies.
Dedicated to finding breakthrough treatments for challenging rare conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
